Diagnostic Value of Serum Paraoxonase-1 Activity and Ceruloplasmin Levels in Patients with Renal Failure

Renal failure is characterized by systemic metabolic, hematological, and biochemical alterations that contribute to accelerated oxidative stress and chronic systemic inflammation. Paraoxonase-1 (PON1) acts as an essential antioxidant enzyme bound to high-density lipoproteins, whereas ceruloplasmin serves as an acute-phase reactant with pro-oxidant potential under pathological conditions. However, the diagnostic utility of their simultaneous alterations in renal impairment remains to be fully elucidated. This study evaluated the diagnostic potential of serum paraoxonase-1 (PON1) activity and ceruloplasmin concentration in patients with renal failure. A case-control study was conducted comprising 60 renal failure patients and 30 age- and gender-matched healthy controls. Fasting blood samples were collected to analyze standard hematological, metabolic, renal, and hepatic parameters, along with serum PON1 activity (spectrophotometrically) and ceruloplasmin levels (nephelometrically). Renal failure patients demonstrated significant hematological impairments (decreased RBC, Hb, hematocrit, WBC, and platelets; (P<0.05) and metabolic dysregulation, including elevated serum glucose, triglycerides, and cholesterol alongside reduced total protein and albumin (P<0.05). Serum urea, creatinine, uric acid, potassium, and phosphorus were significantly elevated, whereas sodium was decreased ( P<0.05 ). Serum PON1 activity was significantly reduced in renal failure patients compared to healthy controls ( 226.1 ± 135.4 vs. 758.5 ± 353.9 nmol/ml/min, P<0.001), whereas serum ceruloplasmin concentration was significantly higher ( 262.6 ± 40.9 vs. 233.3 ± 37.8 mg/L, P<0.001 ). In conclusion, the reciprocal shift in serum PON1 activity and ceruloplasmin concentration reflects impaired antioxidant defense and a heightened inflammatory state in renal failure, serving as useful non-invasive biomarkers associated with renal impairment

Authors

Institutions

Publication Details

Journal
Journal of Science Research and Reviews
Published
2026-11-16
DOI
https://doi.org/10.70882/josrar.2026.v3i6.303
Primary Topic
Paraoxonase enzyme and polymorphisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Diagnostic Value of Serum Paraoxonase-1 Activity and Ceruloplasmin Levels in Patients with Renal Failure

Saad M. Saeed
Journal of Science Research and Reviews
Paraoxonase enzyme and polymorphisms
article

Diagnostic Value of Serum Paraoxonase-1 Activity and Ceruloplasmin Levels in Patients with Renal Failure

Saad M. Saeed
article en

Abstract

Renal failure is characterized by systemic metabolic, hematological, and biochemical alterations that contribute to accelerated oxidative stress and chronic systemic inflammation. Paraoxonase-1 (PON1) acts as an essential antioxidant enzyme bound to high-density lipoproteins, whereas ceruloplasmin serves as an acute-phase reactant with pro-oxidant potential under pathological conditions. However, the diagnostic utility of their simultaneous alterations in renal impairment remains to be fully elucidated. This study evaluated the diagnostic potential of serum paraoxonase-1 (PON1) activity and ceruloplasmin concentration in patients with renal failure. A case-control study was conducted comprising 60 renal failure patients and 30 age- and gender-matched healthy controls. Fasting blood samples were collected to analyze standard hematological, metabolic, renal, and hepatic parameters, along with serum PON1 activity (spectrophotometrically) and ceruloplasmin levels (nephelometrically). Renal failure patients demonstrated significant hematological impairments (decreased RBC, Hb, hematocrit, WBC, and platelets; (P<0.05) and metabolic dysregulation, including elevated serum glucose, triglycerides, and cholesterol alongside reduced total protein and albumin (P<0.05). Serum urea, creatinine, uric acid, potassium, and phosphorus were significantly elevated, whereas sodium was decreased ( P<0.05 ). Serum PON1 activity was significantly reduced in renal failure patients compared to healthy controls ( 226.1 ± 135.4 vs. 758.5 ± 353.9 nmol/ml/min, P<0.001), whereas serum ceruloplasmin concentration was significantly higher ( 262.6 ± 40.9 vs. 233.3 ± 37.8 mg/L, P<0.001 ). In conclusion, the reciprocal shift in serum PON1 activity and ceruloplasmin concentration reflects impaired antioxidant defense and a heightened inflammatory state in renal failure, serving as useful non-invasive biomarkers associated with renal impairment

Journal of Science Research and ReviewsVol. 3(6)
Ministry of Education (IQ), University of Diyala (IQ)
Good health and well-being
Paraoxonase enzyme and polymorphisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon